Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3
โ Scribed by Kaname Yamamoto; Shinichi Yoshino; Goukei Shue; Masakazu Nagashima
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 248 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Objective. To assess the effects of intraarticular (IA) corticosteroid use on bone metabolism in patients with rheumatoid arthritis (RA). Methods. Levels of the bone turnover markers, serum osteocalcin (BGP) and urinary pyridinoline (PYD), were monitored in RA patients for 4 weeks following a s
## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions
The aim of this study was to investigate whether the degree of inflammatory activity, the anatomical stage and various treatments have an influence on bone turnover in patients with rheumatoid arthritis (RA). Osteocalcin (OC) and other parameters of bone turnover were measured in 131 patients with R